Reubi J C, Horisberger U, Laissue J
Division of Cell Biology and Experimental Cancer Research, University of Berne, Switzerland.
Int J Cancer. 1994 Mar 1;56(5):681-8. doi: 10.1002/ijc.2910560513.
Somatostatin receptors were detected in peritumoral veins of various human cancer tissue specimens. Vascular and neoplastic tissue from 14 colonic adenocarcinomas, 13 carcinoids, 6 renal-cell carcinomas and 7 malignant lymphomas were analyzed for somatostatin receptors by use of quantitative receptor autoradiography. In colonic carcinoma specimens, the peritumoral vessels expressed a high density of somatostatin receptors, whereas the neoplastic tissue itself was receptor-negative in many cases. In contrast, the incidence and density of somatostatin receptors in peritumoral vessels was low in well-differentiated gastrointestinal and bronchial carcinoids, in contrast to the high density of such receptors in the carcinoid tumor tissue. Autochthonous vessels surrounding other tumors such as renal-cell carcinomas or malignant lymphomas also frequently expressed somatostatin receptors. In all cases, the somatostatin receptors were localized in veins, particularly in the smooth-muscle cell layer. They exhibited specific and high-affinity binding of somatostatin-14, somatostatin-28 and octreotide, suggesting a preferential expression of the SSTR2 receptor subtype. Since the vessels of normal non-neoplastic human tissues, e.g. of intestine or lymphatic organs, have few somatostatin receptors, the increased somatostatin receptor expression in peritumoral vessels observed in this study may be linked to the neoplastic process itself. The results suggest that somatostatin and somatostatin receptors may play a regulatory role for hemodynamic tumor-host interactions, possibly involving tumor stroma generation, tumor environment, angiogenesis and, particularly, vascular drainage of poorly differentiated neoplasms.
在各种人类癌症组织标本的瘤周静脉中检测到生长抑素受体。通过定量受体放射自显影术分析了来自14例结肠腺癌、13例类癌、6例肾细胞癌和7例恶性淋巴瘤的血管和肿瘤组织中的生长抑素受体。在结肠癌标本中,瘤周血管表达高密度的生长抑素受体,而肿瘤组织本身在许多情况下受体呈阴性。相比之下,高分化胃肠道和支气管类癌的瘤周血管中生长抑素受体的发生率和密度较低,而类癌肿瘤组织中此类受体的密度较高。其他肿瘤(如肾细胞癌或恶性淋巴瘤)周围的自身血管也经常表达生长抑素受体。在所有病例中,生长抑素受体定位于静脉,特别是平滑肌细胞层。它们对生长抑素-14、生长抑素-28和奥曲肽表现出特异性和高亲和力结合,提示SSTR2受体亚型优先表达。由于正常非肿瘤性人类组织(如肠道或淋巴器官)的血管中生长抑素受体很少,本研究中观察到的瘤周血管中生长抑素受体表达增加可能与肿瘤形成过程本身有关。结果表明,生长抑素和生长抑素受体可能在血液动力学肿瘤-宿主相互作用中起调节作用,可能涉及肿瘤基质生成、肿瘤微环境、血管生成,特别是低分化肿瘤的血管引流。